David R. Purdue - Mar 1, 2025 Form 3 Insider Report for AbbVie Inc. (ABBV)

Role: SVP, Controller
Signature: /s/ T.O. Odutayo, Attorney-in-Fact for David R. Purdue
Stock symbol: ABBV
Transactions as of: Mar 1, 2025
Transactions value $: $0
Form type: 3
Date filed: 3/10/2025, 04:28 PM
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	ABBV	Common Stock, $0.01 par value						4.51K	Mar 1, 2025	Direct
holding	ABBV	Common Stock, $0.01 par value						527	Mar 1, 2025	Profit sharing trust	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ABBV	Option (Right to buy)							Mar 1, 2025	Common Stock	3.38K	$149.62	Direct	F2
holding	ABBV	Option (Right to buy)							Mar 1, 2025	Common Stock	5.36K	$175.28	Direct	F3
holding	ABBV	Option (Right to buy)							Mar 1, 2025	Common Stock	5.21K	$192.86	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Balance in AbbVie Savings Program as of March 1, 2025. Balance includes shares acquired pursuant to a dividend reinvestment feature.
F2	Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option became exercisable as to 1,126 shares on 02/16/2024, as to 1,125 shares on 02/16/2025, and will become exercisable as to 1,125 shares on 02/16/2026.
F3	Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option became exercisable as to 1,786 shares on 02/15/2025, and will become exercisable as to 1,786 shares on 02/15/2026, and as to 1,786 shares on 02/15/2027.
F4	Employee stock option granted pursuant to the AbbVie Amended and Restated 2013 Incentive Stock Program. The option becomes exercisable as to 1,736 shares on 02/13/2026, as to 1,736 shares on 02/13/2027, and as to 1,736 shares on 02/13/2028.